Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism.

Ullah, Mujib; Akbar, Asma; Ng, Nathan Norton; Concepcion, Waldo; Thakor, Avnesh S

Ullah, Mujib; Akbar, Asma; Ng, Nathan Norton; Concepcion, Waldo; Thakor, Avnesh S.

Afiliação

Ullah M; Interventional Regenerative Medicine and Imaging Laboratory, Stanford University School of Medicine, Department of Radiology, Palo Alto, CA 94304, USA.
Akbar A; Mid-Florida Research and Education Center, Department of Pathology, University of Florida, Apopka, FL 32703, USA.
Ng NN; Interventional Regenerative Medicine and Imaging Laboratory, Stanford University School of Medicine, Department of Radiology, Palo Alto, CA 94304, USA.
Concepcion W; Interventional Regenerative Medicine and Imaging Laboratory, Stanford University School of Medicine, Department of Radiology, Palo Alto, CA 94304, USA.
Thakor AS; Interventional Regenerative Medicine and Imaging Laboratory, Stanford University School of Medicine, Department of Radiology, Palo Alto, CA 94304, USA.

Oncotarget ; 10(37): 3435-3450, 2019 May 28.

Article em En | MEDLINE | ID: mdl-31191817

Palavras-chave

CD9; MSCs; chemoresistance; cytokine; xenograft tumors

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google